SOLVAC SA-REG (SOLV.BR) Fundamental Analysis & Valuation

EBR:SOLV • BE0003545531

69.4 EUR
-0.6 (-0.86%)
Last: Mar 5, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This SOLV.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall SOLV gets a fundamental rating of 4 out of 10. We evaluated SOLV against 66 industry peers in the Chemicals industry. SOLV has only an average score on both its financial health and profitability. SOLV is valued correctly, but it does not seem to be growing. SOLV also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. SOLV.BR Profitability Analysis

1.1 Basic Checks

  • In the past year SOLV was profitable.
  • Of the past 5 years SOLV 4 years were profitable.
  • In multiple years SOLV reported negative operating cash flow during the last 5 years.
SOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.55%, SOLV is in the better half of the industry, outperforming 62.12% of the companies in the same industry.
  • With a Return On Equity value of 5.00%, SOLV perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
  • SOLV's Return On Invested Capital of 3.65% is in line compared to the rest of the industry. SOLV outperforms 53.03% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SOLV is below the industry average of 6.96%.
  • The 3 year average ROIC (3.44%) for SOLV is below the current ROIC(3.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.55%
ROE 5%
ROIC 3.65%
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
SOLV.BR Yearly ROA, ROE, ROICSOLV.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • SOLV has a better Profit Margin (95.09%) than 98.48% of its industry peers.
  • In the last couple of years the Profit Margin of SOLV has grown nicely.
  • Looking at the Operating Margin, with a value of 97.93%, SOLV belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • SOLV's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 97.93%
PM (TTM) 95.09%
GM N/A
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
SOLV.BR Yearly Profit, Operating, Gross MarginsSOLV.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 100 200 300 400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. SOLV.BR Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, SOLV has about the same amount of shares outstanding.
  • Compared to 5 years ago, SOLV has about the same amount of shares outstanding.
  • The debt/assets ratio for SOLV has been reduced compared to a year ago.
SOLV.BR Yearly Shares OutstandingSOLV.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SOLV.BR Yearly Total Debt VS Total AssetsSOLV.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • SOLV has an Altman-Z score of 4.63. This indicates that SOLV is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.63, SOLV belongs to the best of the industry, outperforming 89.39% of the companies in the same industry.
  • SOLV has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • SOLV has a better Debt to Equity ratio (0.06) than 89.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 4.63
ROIC/WACCN/A
WACCN/A
SOLV.BR Yearly LT Debt VS Equity VS FCFSOLV.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.69 indicates that SOLV may have some problems paying its short term obligations.
  • The Current ratio of SOLV (0.69) is worse than 90.91% of its industry peers.
  • A Quick Ratio of 0.69 indicates that SOLV may have some problems paying its short term obligations.
  • The Quick ratio of SOLV (0.69) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69
SOLV.BR Yearly Current Assets VS Current LiabilitesSOLV.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SOLV.BR Growth Analysis

3.1 Past

  • The earnings per share for SOLV have decreased strongly by -38.57% in the last year.
  • The Earnings Per Share has been growing by 26.70% on average over the past years. This is a very strong growth
  • Looking at the last year, SOLV shows a very negative growth in Revenue. The Revenue has decreased by -38.28% in the last year.
  • Measured over the past years, SOLV shows a very strong growth in Revenue. The Revenue has been growing by 24.62% on average per year.
EPS 1Y (TTM)-38.57%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%28%
Revenue 1Y (TTM)-38.28%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%26.75%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SOLV.BR Yearly Revenue VS EstimatesSOLV.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B
SOLV.BR Yearly EPS VS EstimatesSOLV.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 5 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. SOLV.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.78, the valuation of SOLV can be described as very reasonable.
  • Based on the Price/Earnings ratio, SOLV is valued cheaply inside the industry as 93.94% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.74, SOLV is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 4.78, the valuation of SOLV can be described as very cheap.
  • 100.00% of the companies in the same industry are more expensive than SOLV, based on the Price/Forward Earnings ratio.
  • SOLV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.82.
Industry RankSector Rank
PE 11.78
Fwd PE 4.78
SOLV.BR Price Earnings VS Forward Price EarningsSOLV.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOLV.BR Per share dataSOLV.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • SOLV's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.77
PEG (5Y)0.44
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. SOLV.BR Dividend Analysis

5.1 Amount

  • SOLV has a Yearly Dividend Yield of 5.50%, which is a nice return.
  • SOLV's Dividend Yield is rather good when compared to the industry average which is at 2.21. SOLV pays more dividend than 89.39% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, SOLV pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.5%

5.2 History

  • The dividend of SOLV has a limited annual growth rate of 1.34%.
Dividend Growth(5Y)1.34%
Div Incr Years0
Div Non Decr Years0
SOLV.BR Yearly Dividends per shareSOLV.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • SOLV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
SOLV.BR Yearly Income VS Free CF VS DividendSOLV.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

SOLV.BR Fundamentals: All Metrics, Ratios and Statistics

SOLVAC SA-REG

EBR:SOLV (3/5/2026, 7:00:00 PM)

69.4

-0.6 (-0.86%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06
Earnings (Next)03-06
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.24%
Ins Owner ChangeN/A
Market Cap1.48B
Revenue(TTM)132.44M
Net Income(TTM)125.93M
Analysts44
Price Target108.27 (56.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.5%
Yearly Dividend5.8
Dividend Growth(5Y)1.34%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.78
Fwd PE 4.78
P/S 11.2
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 0.59
EV/EBITDA N/A
EPS(TTM)5.89
EY8.49%
EPS(NY)14.52
Fwd EY20.93%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.19
BVpS117.7
TBVpS117.7
PEG (NY)1.77
PEG (5Y)0.44
Graham Number124.89
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 5%
ROCE 4.86%
ROIC 3.65%
ROICexc 3.74%
ROICexgc 3.74%
OM 97.93%
PM (TTM) 95.09%
GM N/A
FCFM N/A
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
ROICexc(3y)3.44%
ROICexc(5y)N/A
ROICexgc(3y)3.61%
ROICexgc(5y)N/A
ROCE(3y)4.58%
ROCE(5y)N/A
ROICexgc growth 3Y-27.07%
ROICexgc growth 5Y31.12%
ROICexc growth 3Y-24.14%
ROICexc growth 5Y34%
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z 4.63
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.57%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%28%
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.28%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%26.75%
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.25%
EBIT growth 3Y-28.15%
EBIT growth 5Y27.7%
EBIT Next Year44.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.44%
OCF growth 3YN/A
OCF growth 5YN/A

SOLVAC SA-REG / SOLV.BR FAQ

Can you provide the ChartMill fundamental rating for SOLVAC SA-REG?

ChartMill assigns a fundamental rating of 4 / 10 to SOLV.BR.


What is the valuation status of SOLVAC SA-REG (SOLV.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to SOLVAC SA-REG (SOLV.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for SOLVAC SA-REG?

SOLVAC SA-REG (SOLV.BR) has a profitability rating of 5 / 10.


How financially healthy is SOLVAC SA-REG?

The financial health rating of SOLVAC SA-REG (SOLV.BR) is 4 / 10.